Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Ansichten
• 07/30/23
0
0
Einbetten
administrator
Abonnenten
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare